Manuel Hidalgo Medina has served as a member of Guardant Health’s board of directors since July 2024. Dr. Hidalgo has served as chief of the division of hematology and medical oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center since 2019 where he oversees clinical and translational research in hematology and medical oncology and is the Walter B. Wriston Professor of Pancreatic Cancer Research. Prior to his current position, Dr. Hidalgo served as chief of the division of hematology at Beth Israel Deaconess Medical Center in Boston and clinical director of the Rosenberg Clinical Cancer Center from 2015 to 2019. During this time, he was the Theodore W. and Evelyn G. Berenson professor of medicine at Harvard Medical School. Dr. Hidalgo also held leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid and at the Kimmel Comprehensive Cancer Center, where he was director of gastrointestinal oncology program.
Dr. Hidalgo currently serves as a member of the board of directors of Bristol-Myers Squibb Company. He received his Medical Degree from the University of Navarra in Pamplona, Spain, and a Doctorate in infectious diseases and cancer from the University Autónoma of Madrid, Spain. He completed his Residency training in Medical Oncology at the Hospital 12 de Octubre in Madrid and his Fellowship in Medical Oncology at the University of Texas Health Science Center in San Antonio, Texas, where he also served as an Assistant Professor of Medicine.
- Member of the Nominating and Corporate Governance Committee